DHA brain uptake and APOE4 status: a PET study with [1-11C]-DHA

Hussein N Yassine,Joseph R Hibbeln,Varun Rawat,Stephen C Cunnane,Stanley I Rapoport,John C Umhau,Etienne Croteau

doi:10.1186/s13195-017-0250-1

Abstract

BackgroundThe apolipoprotein E ɛ4 (APOE4) allele is the strongest genetic risk factor identified for developing Alzheimer’s disease (AD). Among brain lipids, alteration in the ω-3 polyunsaturated fatty acid docosahexaenoic acid (DHA) homeostasis is implicated in AD pathogenesis. APOE4 may influence both brain DHA metabolism and cognitive outcomes.MethodsUsing positron emission tomography, regional incorporation coefficients (k*), rates of DHA incorporation from plasma into the brain using [1-11C]-DHA (Jin), and regional cerebral blood flow using [15O]-water were measured in 22 middle-aged healthy adults (mean age 35 years, range 19–65 years). Data were partially volume error-corrected for brain atrophy. APOE4 phenotype was determined by protein expression, and unesterified DHA concentrations were quantified in plasma. An exploratory post hoc analysis of the effect of APOE4 on DHA brain kinetics was performed.ResultsThe mean global gray matter DHA incorporation coefficient, k*, was significantly higher (16%) among APOE4 carriers (n = 9) than among noncarriers (n = 13, p = 0.046). Higher DHA incorporation coefficients were observed in several brain regions, particularly in the entorhinal subregion, an area affected early in AD pathogenesis. Cerebral blood flow, unesterified plasma DHA, and whole brain DHA incorporation rate (Jin) did not differ significantly between the APOE groups.ConclusionsOur findings suggest an increase in the DHA incorporation coefficient in several brain regions in APOE4 carriers. These findings may contribute to understanding how APOE4 genotypes affect AD risk.

Highlights

The apolipoprotein E ɛ4 (APOE4) allele is the strongest genetic risk factor identified for developing Alzheimer’s disease (AD)
We focused on the medial temporal lobe subregions, given their significance in AD, with FreeSurfer segmentation to assess Region of interest (ROI) [1-11C]docosahexaenoic acid (DHA) kinetics. p ≤ 0.05 was considered a significant difference
DHA incorporation coefficient, k* The mean global gray matter k* was 16% higher in APOE4 carriers than in noncarriers (p = 0.04) (Fig. 2a). k* was significantly higher in several gray matter subregions (Table 2), but it did not differ in the white matter by Apolipoprotein E (APOE) subgroup

Summary

Introduction

The apolipoprotein E ɛ4 (APOE4) allele is the strongest genetic risk factor identified for developing Alzheimer’s disease (AD). APOE4 may influence both brain DHA metabolism and cognitive outcomes. Apolipoprotein E ɛ4 (APOE4) genotype is the strongest genetic risk factor for late-onset or sporadic Alzheimer’s disease (AD). APOE’s affinity for the low-density lipoprotein receptor is known to differ between isoforms (APOE4 > APOE3 > APOE2) [1]. These differences have implications for the metabolism of APOE lipoprotein particles and the amount of lipid carried by APOE. APOE forms high-density lipoprotein particles and participates in exchange of lipids between glial cells and neurons [2].

Objectives

Methods

Results

Discussion

Conclusion